← All trials
NCT01518036
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 14, 1987
- Primary completion
- Apr 11, 2004
- Completion date
- Apr 11, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 57
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Novo NordiskLead sponsor
- Novo NordiskStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.